Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-13
2008-05-13
Stockton, Laura L. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S371000
Reexamination Certificate
active
07371869
ABSTRACT:
The present invention relates to compounds of the formulawhich are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
REFERENCES:
patent: WO 99/01426 (1999-01-01), None
patent: WO 99/05117 (1999-02-01), None
patent: WO 01/83478 (2001-11-01), None
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.
J. M. English et al.,Trends in Pharm. Sci. 2002, 23(1), 40.
J. L. Bos,Cancer Res. 1989, 49, 4682.
A. Bonni et al.,Science1999, 286, 1358.
H. Davies et al.,Nature2002, 417, 949.
R. Herrera et al.,Trends Mol. Med. 2002, 8(4, Suppl.), S27.
C. F. Zheng et al.,J. Biol. Chem. 1993, 268, 11435.
S. Cowley et al.,Cell1994, 77, 841.
R. Seger et al.,J. Biol. Chem. 1992, 267, 14373.
Goodnow, Jr. Robert Alan
Huby Nicholas J. S.
Kong Norman
McDermott Lee Apostle
Moliterni John Anthony
Hoffmann-La Roche Inc.
Johnston George W.
Rocha-Tramaloni Patricia S.
Stockton Laura L.
LandOfFree
Substituted hydantoins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted hydantoins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted hydantoins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2813276